Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Diabetes monitoring | Image credit: abidika - stock.adobe.com

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

By Pearl Steinzor

April 23rd 2025

A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 diabetes—but not all obesity-related cancers show a link.

Rural health sign | Image credit: BJP7images - stock.adobe.com

FQHCs Show Low Engagement in Hypertension, Diabetes Trials

By Pearl Steinzor

April 15th 2025

AI representation of housing stability | Image credit: GoldPumaze - stock.adobe.com

Housing Instability Linked to Worse Type 2 Diabetes Outcomes

By Pearl Steinzor

April 14th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com

GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

By Pearl Steinzor

April 9th 2025

AJMC

The Role of Advanced Technologies in Improving Diabetes Outcomes

By David G. Marrero, PhD
Christopher G. Parkin, MS

April 7th 2025

More News

Statement: CGM Trials Need Standards, Safety Reports Must Be Transparent

October 28th 2017

Statement: CGM Trials Need Standards, Safety Reports Must Be Transparent

Authors from a working group of the American Diabetes Association and the European Association for the Study of Diabetes made recommendations that could lead to broader use of technology. CGM systems are poised to make advances that could make them more useful to the larger group of patients with type 2 diabetes.

October 27th 2017

The New Normal: How Value-Based Care Is Reaching More Patients at One Insurer

While Congress debates the fate of the Affordable Care Act, healthcare transformation continues, as seen in an update released this week at Horizon Blue Cross Blue Shield of New Jersey.

October 27th 2017

The New Normal: How Value-Based Care Is Reaching More Patients at One Insurer

While Congress debates the fate of the Affordable Care Act, healthcare transformation continues, as seen in an update released this week at Horizon Blue Cross Blue Shield of New Jersey.

October 24th 2017

Statewide Data Infrastructure Supports Population Health Management: Diabetes Case Study

Craig Jones, MD Mary Kate Mohlman, PhD David Jorgenson, MS Karl Finison, MA Katie McGee, MS Hans Kastensmith

The use of statewide data infrastructure is effective at identifying criteria for diabetes outreach and management at the whole-population level.

October 23rd 2017

Teens Are Sleeping Less, and Smartphones Are Blamed

The authors find that sleep in teens fell after 2009, as smartphone use escalated. Lack of sleep has been linked to insulin resistance.

Podcast: This Week in Managed Care - Bipartisan ACA Deal and Other Health News

October 21st 2017

Podcast: This Week in Managed Care - Bipartisan ACA Deal and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

October 21st 2017

Gottlieb: Puerto Rico's Medical Device Sector Hit Even Harder Than Pharma by Hurricane

The FDA commissioner said regulators would keep special watch over 10 manufacturers who are the sole source of key products. If necessary, they will allow products to be imported from overseas.

This Week in Managed Care: October 20, 2017

October 20th 2017

This Week in Managed Care: October 20, 2017

This week, the top managed care news included the bipartisan deal to stabilize the Affordable Care Act's insurance markets; coverage from the Academy of Managed Care Pharmacy 2017 Nexus; and a plan to reduce clinician burnout at the computer.

October 20th 2017

Solera Health, ADA to Connect At-Risk Americans to Prevent Diabetes

Despite its clinical success the Diabetes Prevention Program has only reached a fraction of those who need it. That could change once Medicare starts paying for the program next year.

October 18th 2017

FDA Panel Gives Nod to Once-Weekly Semaglutide for Type 2 Diabetes

The injectible drug is expected to compete with Eli Lilly's Trulicity after a head-to-head trial showed superior results on glycemic control and weight loss.

October 17th 2017

Looking Ahead at the Specialty Drug Pipeline After an Active Year of Approvals

Christina Mattina

Aimee Tharaldson, PharmD, of Express Scripts kicked off the Academy of Managed Care Pharmacy (AMCP) 2017 Nexus, held October 16-19 in Dallas, Texas, with a presentation on the pipeline of specialty pharmaceuticals in development.

October 16th 2017

Gestational Diabetes Raises Heart Attack, Stroke Risk, NIH Study Finds

Authors of an editorial suggest pregnancy serves as an early stress test on the body, and women who develop gestational diabetes should see it as a signal to adopt a healthy lifestyle.

October 16th 2017

Study: Linoleic Acid Is Beneficial for Prevention of Type 2 Diabetes

Jaime Rosenberg

With little research on the effects of omega-6 polyunsaturated acids in the prevention of type 2 diabetes (T2D), the study focused on the link between linoleic acid and arachidonic acid biomarkers with incident T2D.

October 13th 2017

Findings Point Toward Customized Diabetes Prevention

The findings generated data on 19 specific clinical variables that could help physicians and patients made personalized decisions about diabetes prevention.

October 12th 2017

Patients With Diabetes Hospitalized Less When Enrolled in Special Needs Plans

Alison Rodriguez

Specialized Medicare Advantage plans called chronic condition special needs plans (C-SNPs), may demonstrate greater improvement in outcomes and utilization of care for the beneficiaries when compared to non-SNP Medicare plans, according to a new analysis from Avalere Health.

October 11th 2017

Child and Adolescent Obesity Dramatically Increased Since 1975

Jaime Rosenberg

A new study focused on worldwide trends of body mass index, underweight, overweight, and obesity in children and adolescents over 4 decades and found the number of obese children and adolescents has increased by more than 10-fold.

October 10th 2017

Study of MAIT Cells Suggests Biomarker for Type 1 Diabetes

Researchers have focused on changes in the gut bacteria to figure out who is at risk for a loss of beta cell function.

October 9th 2017

Why Thaler's Nobel Prize in Economics Matters in Diabetes Care

Healthcare experts increasingly recognize that behavioral science will provide the ideas for reducing the $245 billion annual cost of diabetes in the United States.

Podcast: This Week in Managed Care - Finding a New HHS Secretary, and Other Health News

October 7th 2017

Podcast: This Week in Managed Care - Finding a New HHS Secretary, and Other Health News

Every week, The American Journal of Managed CareÂ® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

October 6th 2017

CDC Calls Attention to Connections Between Obesity and Cancer

The US Preventive Services Task Force already has recommendations for screening and intervention for obesity, but they often are not followed.

October 6th 2017

5 Takeaways From the diaTribe Foundation Innovation Lab

Scaling behavioral change and reducing diabetes at the population level were major themes of the meeting.

This Week in Managed Care: October 6, 2017

October 6th 2017

This Week in Managed Care: October 6, 2017

This week, the top managed care stories included speculation regarding who would replace Tom Price, MD, as HHS secretary; a report on breast cancer mortality trends and racial disparities from 1989 to 2015; and the FDA announced new strategies to improve patient access to less expensive drugs.

October 6th 2017

Animas to Leave the Insulin Pump Market Amid Competitive Pressures

The announcement does not affect LifeScan, which makes blood glucose management tools and apps. Company officials said an exclusivity deal between Medtronic and UnitedHealthcare was among the factors that contributed to the decision.

October 5th 2017

Sanofi, Regeneron Win New Trial in PCSK9 Patent Dispute

The fight for dominance of the market for a costly cholesterol drug continues, even as sales fall short of expectations.

Dr Paul Chew Explains How Medicare DPP Can Benefit From Digital Providers

October 5th 2017

Dr Paul Chew Explains How Medicare DPP Can Benefit From Digital Providers

CMS’ decision to exclude digital health from its proposal for the Medicare Diabetes Prevention Program (DPP) has caused a controversy, explained Paul Chew, MD, chief medical officer of Omada Health.

October 4th 2017

Meta-Analysis Links Night Shift to Obesity Risk, Especially "Belly Fat"

The review of 28 studies found that night shift workers were at particularly high risk of developing the type of abdominal obesity associated with heart disease.

October 3rd 2017

Always a Bright Spot: Catching Up With diaTribe's Adam Brown

The author, who has lived with type 1 diabetes for 16 years, offers practical advice on food, exercise, mindset, and sleep.

October 2nd 2017

Janssen Files With FDA for CV Indication for Canagliflozin

The filing also seeks new indications for fixed-dose combinations of canagliflozin and metformin.

October 2nd 2017

Studies on "Body Clock" Win Nobel Prize in Medicine

This is the second year in a row that the prize in Medicine or Physiology has been awarded for work that yielded understanding of chronic disease.

October 2nd 2017

Afrezza Gets Label Update; MannKind to Launch New Talks With Payers

The CEO said the changes will finally allow the company to set the inhaled insulin apart from its rivals.

...

31 32 33 34 35 36 37 38 39

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions